Saptagir Laboratories Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 17.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 15.78 Cr
as on 16-06-2024
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 16.90 Cr
as on 16-06-2024
- Revenue 18.27%
(FY 2023)
- Profit 19212.26%
(FY 2023)
- Ebitda 317.59%
(FY 2023)
- Net Worth 39.26%
(FY 2023)
- Total Assets 0.88%
(FY 2023)
About Saptagir Laboratories
The Corporate was formerly known as Astrica Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 17.00 Cr and a paid-up capital of Rs 15.78 Cr.
The company has closed loans amounting to ₹16.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Saptagir Laboratories Private Limited India is Dilip Toshniwal as COMPANY SECRETARY. Ranga Mallepalli, Narayana Nambu, and Silpa Reganti serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC054831
- Company No.
054831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2007
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Saptagir Laboratories?
Executive Team (2)
SR
Silpa Reganti
Managing DirectorAppointment Date: 17-Mar-2020
Status: Current
DT
Dilip Toshniwal Company SecretaryAppointment Date: 09-Jun-2020
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Saptagir Laboratories.
Saptagir Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.27% increase. The company also saw a substantial improvement in profitability, with a 19212.26% increase in profit. The company's net worth Soared by an impressive increase of 39.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saptagir Laboratories?
In 2023, Saptagir Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deneb Enterprises Private Limited
Active
5 years 7 months Ranga Mallepalli and Narayana Nambu are mutual person
Dorado Corporation Private Limited
Active 11 years 5 months Ranga Mallepalli and Narayana Nambu are mutual person
Sweet Acres Farms Corporation Private Limited
Active 11 years 5 months Narayana Nambu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jul 2015 | ₹16.90 Cr | Satisfied |
How Many Employees Work at Saptagir Laboratories?
Saptagir Laboratories has a workforce of 58 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Nov 30, 2018, Saptagir Laboratories has raised a total of ₹ 31.19 Cr, with the most recent deal valued at ₹ 1 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
